Afanas’eva, T. N. and N. P. Lebkova (1987). “[Effect of Eleutherococcus on the subcellular structures of the heart in experimental myocardial infarct].” Biull Eksp Biol Med 103(2): 212-5.

Azizov, A. P. (1997). “[Effects of eleutherococcus, elton, leuzea, and leveton on the blood coagulation system during training in athletes].” Eksp Klin Farmakol 60(5): 58-60.

Baranov, A. I. (1982), “Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature.” J Ethnopharmacol 6(3): 339-53.

Bazaz’ian, G. G., L. A. Liapina, et al. (1987). “[Effect of Eleutherococcus on the functional status of the anticoagulation system in older animals].” Fiziol Zh SSSR Im I M Sechenova 73(10):
1390-5.

Ben-Hur, E. and S. Fulder (1981). “Effect of Panax ginseng saponins and Eleutherococcus senticosus on survival of cultured mammalian cells after ionizing radiation.” Am J Chin Med
9(1): 48-56.

Bespalov, V. G, V. A Aleksandrov, et al. (1992). “[The inhibiting effect of phytoadaptogenic preparations from bioginseng, Eleutherococcus senticosus and Rhapontioum carthamoides on the development of nervous system tumors in rats induced by N-nitrosoethylurea] .“ Vopr Onkol
38(9): 1073-80.

Bol’shakova, I. V., E. L. Lozovskaia, et al (1997). “[Antioxidant properties of a series of extracts from medicinal plants].” Biofizika 42(2): 480-3.

Chubarev, V. N., E. R. Rubtsova, et al. (1989). “[Immunotropic effect of a tincture of the tissue culture biomass of ginseng cells arid of an Eleutherococcus extract in mice].” Farmakol Toksikol
52(2): 55-9.

Davydov. M. and A D. Krikorian (2000). “Eleutherococcus’senticosus (Rupr. & Maxim) Maxim. (Araliaceae) as an adaptogen: a closer look” J Ethnopharmacol 72(3): 345-93.

Deyama, T., S. Nishibe, et al. (2001). “Constituents and pharmacological effects of Eucommia and Siberian ginseng.” Acta Phammeol Sin 22(12): 1057-70.

Donovan, J. L., C. L. DeVane, et al. (2003). “Siberian Ginseng (Eleutheroccus senticosus)
Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers.” Drug Metab Dispos 31(5):
519-22.

Dowling, E. A., D. R. Redondo, et al. (1996). “Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance.” Med Sci Sports Exerc 28(4): 482-9.

Drozd, J., T. Sawicka, et al. (2002). “Estimation of humoral activity of Eleutherococcus senticosus.” Acta Pol Pharm 59(5): 395-401.

Eschbach, L. F., M. J. Webster, et al. (2000), “The effect of siberian ginseng (Eleutherococcus
senticosus) on substrate utilization and performance.” Int J Sport Nutr Exerc Metab 10(4): 444-
51.

Filaretov, A. A., T. S. Bogdanova, et al (1986). “[Effect of adaptogens on the activity of the pituitary-adrenocortical system in rats].” Biull Eksp Biol Med 101(5): 573-4.

Gaffney, B. T., H. M. Hugel, et al. (2001). “The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes.” Life Sci 70(4): 431-42.

Gaffney, B. T., H. M. Hugel, et al. (2001). “Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors.” Med Hypotheses 56(5): 567-72.

Glatthaar-Saalmuller, B., F. Sachet, et al. (2001). “Antiviral activity of an extract derived from roots of Eleutherococcus senticosus.” Antiviral Res 50(3): 223-8.

Golotin, V. G., V. A. Gonenko, et al. (1989). “[Effect of ionol and eleutherococcus on changes of the hypophyseo-adrenal system in rats under extreme conditions].” Vopr Med Khim 35(1): 35-7

Hikino, H., M. Takahashi, et al. (1986). “Isolation and hypoglycemic activity of eleutherans A, B, C, D, E, F, and G. glycans of Eleutherococcus senticosus roots.” J Nat Prod 49(2): 293-7.

Jeong, H. J., H. N. Koo, et al. (2001). “Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian Ginseng.” Immunopharmacol Immunotoxicol 23(1): 107-17.

Kaloeva, Z. D. (1986). “[Effect of the glycosides of Eleutherococcus senticosus on the hemodynamic indices of children with hypotensive states].” Farmakol Toksikol 49(5): 73.

Khetagorova, L. G. and A. Romanov Iu (1992). “[Effects of phytoadaptogens on biorhythms of indicators of the hemostasis system in dogs].” Biull Eksp Biol Med 113(1): 87-9.

Khetagurova, L, G., T. N. Gonobobleva, et al (1991). “[Effects of Eleutherocoecus on the biorhythm of indices of peripheral blood in dogs].” Biull Eksp Biol Med 111(4): 402-4.

Kropotov, A. V., O. L. Kolodnyak, et al. (2002). “Effects of Siberian ginseng extract and ipriflavone on the development of glucocorticoid-induced osteoporosis.” Bull Exp Biol Med
133(3): 252-4.

Kupin, V. I. and E. B. Polevaia (1986). “[Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].” Vopr Onkol 32(7): 21-6.

Kupin, V. I., E. B. Polevaia, et al. (1987). “[Immunomodulating action of an Eleuterococcus extract in oncologic patients].” Sov Med(5): 114-6.

Maimeskuloa, L. A. and L. N. Maslov (2000). “[Anti-arrhythmic effect of phytoadaptogens].” Eksp Klin Farmakol 63(4): 29-31.

Martinez, B. and E. J. Staba (1984). “The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats.” Jpn J Pharmacol 35(2): 79-85.

Maslova, L. V., B. Lishmanov Iu, et. al. (1993). “[Cardioprotective effects of adaptogens of plant origin].’ BiuII Eksp Biol Med 115(3): 269-71.

Medon, P. J., P. W. Ferguson, et al. (1984). “Effects of Eleutherococcus senticosus extracts on hexobarbital metabolism in vivo and in vitro.” J. Ethnopharmacol 10(2): 235-41.

Molokovskii, D. S., V. V. Davydov, et al. (1989). “[The action of adaptogenic plant preparations in experimental alloxan diabetes].” Probl Endokrinol (Mosk) 35(6): 82-7.

Novikov, V. S., V. N. Bortnovskii, et al. (1987). “[Efficacy of the use of biologically active substances to increase the body resistance in sailors].” Voen Med Zh(1O): 50-1.

Provalova, N. V., E. G. Skurikhin, et al. (2002). “Mechanisms underling the effects of adaptogens on erythropoiesis during paradoxical sleep deprivation.” Bull Exp Biol Med 133(5):
428-32.

Rege, N. N., U. M. Thatte, at al (1999). “Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine.” Phytother Res 13(4): 275-91.

Steinmann, G. G., A Esperestez et al. (2001). “Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts.” Arzneimittelforschung 51(1): 76-83.

Szolomicki, J., L. Samochowiec, et al, (2000). “The influence of active components of
Eleutherococcus senticosus on cellular defence and physical fitness in man.” Phytother Res
14(1): 30-5.

Wildfeuer, A. and D. Mayerhofer (1994). “[The effects of plant preparations on cellular functions in body defense].” Arzneimittelforschung 44(3): 361-6.

Williamson, E. M. (2000). “S. Szolmicki, L. Samocliowiec, Wojcicki and M. Drozdzik, ‘The influence of active components of eleutherococcus senticosus on cellular defence and physical fitness in man’. Phytotherapy research 14(1)2000,30-35.” Phytother Res 14(3): 225.

Yu, C. Y., S. H. Kim, et al. (2003). “Intraspecific relationship analysis by DNA markers and in vitro cytotoxic and antioxidant activity in Eleutherococcus senticosus.” Toxicol In Vitro 17(2):
229-3 6,

Azizov. A.P. and R.D. Seifulla (1998). “[The effect of elton, leveton, fitoton and adapton on the work capacity of experimental animals].” Eksp Kin Farmakol 61(3): 61-3.

Chen, Y.G., G. W. Qin, et al. (2001). “Triterpenoid acids from Schisandra propinqua with cytotoxic effect on rat luteal cells and human decidual cells in vitro.” Fitoterapia 72(4): 435-7.

Chiu, P. Y., D. H. Mak, et al. (2002). “In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin.” Planta Med 68(11): 951-6.

Cyong, J. C., S. M. Ki, et al. (2000). “Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine.” Am J Chin Med 28(3-4): 351-60.

Hsieh, T. C., X. Lu, et al. (2002). “Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies.” Int J Oncol
20(4): 681-9.

Ip, S. P., D. H. Mak, et al. (1996). “Effect of a lignan-enriched extract of Schisandra chinensis on afiatoxin B1 and cadmium chloride-induced hepatotoxicity in rats.” Pharmacol Toxicol 78(6):
413-6.

Ip, S. P., M. K. Poon, et al, (1996). “Schisandrin B protects against carbon tetrachloride toxicity by enhancing the mitochondrial glutathione redox status in mouse liver.” Free Radic Biol Med
21(5): 709-12.

Ip, S. P., H. Y. Yiu, et al. (2000). ‘Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice.” Mol Cell Biochem 205(1-2): 111-4.

Ip, S. P., H. Y. Yiu, et al. (2000). “Schisandrin B protects against menadione-induced hepatotoxicity by enhancing DT-diaphorase activity.” Mol Cell Biochem 208(1-2): 151-5.

Ko, K. M., S. P. Ip, et al. (1995). “Effect of a lignan-enriched fructus schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachioride toxicity.” Planta Med
61(2): 134-7.

Kubo, S., Y. Ohkura, et al. (1992). “Effect of Gomisin A (TJN-101) on liver regeneration.” Planta Med 58(6): 489-92.

Lee, I. S., K. Y. Jung, et al. (1999). “Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. Biol Pharm Bull 22(3): 265-7.

Lee, I. S., H. K. Lee, et al. (2003). “Lignans with inhibitory activity against NFAT transcription from Schisandra chinensis.” Planta Med 69(1): 63-4.

Li, P. C., K. T. Poon, et al. (1996). “Schisandra chinensis-dependent myocardial protective action of sheng-mai-san in rats.” Am J Chin Med 24(3-4): 255-62.

Lu, H. and 0. T. Liu (1992), “Anti-oxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae.” Planta Med 58(4): 311-3.

Ohkura, Y., Y. Mizoguchi, et al. (1990). “Effect of gomisin A (TJN-101) on the arachidonic acid cascade in macrophages.” Jpn J Pharmacol 52(2): 331-6.

Ohkura, Y., Y. Mizoguchi, et al. (1987). “Inhibitory effect of TJN-101 ((+)-(6S,7S,R-biar)-
5,6,7,8-tetrahydro- 1,2,3, 12-tetramethoxy -6,7-dimethyl-10,11- methylenedioxy-6-
dibenzo[a,c] cyclooctenol) on immunologically induced liver injuries.” Jpn J Pharmacol 44(2):
179-85.

Ohsugi, M., W. Fan, et al. (1999). “Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra.” J Ethnopharmacol 67(1): 111-
9.

Opletal, L., M. Krenkova, et al. (2001). “[Phytotherapeutic aspects of diseases of the circulatory system. 7. Schisandra chinensis (Turcz.) Baill.): its composition and biological activitvy.” Ceska Slov Farm 50(4): 173-80.

Opletal, L., M. Krenkova, et al. (2001), “[Phytotherapeutic aspects of diseases of the circulatory system 8. Chinese magnolia (Schisandra chinensis (Turcz.) Baill.): production of the drugs and their evaluation, therapeutic and dietary preparations].” Ceska Slov Farm 50(5): 219-24.

Pan, S. Y., Y. F. Han, et al. (2002). “Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice.” Planta Med 68(3): 217-20.

Sun, H. D., S. X. Qiu, et al. (1996). “Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase.” J Nat Prod 59(5): 525-7.

Takeda, S., I. Arai, et al. (1988). “[Effect of gomisin A(TJN-101), a lignan compound isolated from Schisandra fruits, on liver function in rats].” Nippon Yakurigaku Zasshi 91(4): 237-44.

Takeda, S., Y. Kase, et al (1987). “[Effects ofTJN-l01, a lignan compound isolated from Schisandra fruits, on liver fibrosis and on liver regeneration after partial hepatectomy in rats with chronic liver injury induced by CC14].” NipponYakurigaku Zasshi 90(1): 51-65.

Yasukawa, K, Y. Ikeya, et al. (1992). “Gomisin A inhibits tumor promotion by 12-0-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin.” Oncology 49(1):
68-71.

Zhu, M., K. F. Lin, et al. (1999). “Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CC14 intoxication model.” J Ethnopharmacol 67(1): 61-8.

Zhu, M., R. Y. Yeung, et al. (2000). “Improvement of phase I drug metabolism with Sehisandra chinensis against CC14 hepatotoxicity in a rat model.” Planta Med 66(6): 521-5.

Baranov, A. I. (1982). “Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature.” J Ethnopharmacol 6(3): 339-53.

Bol’shakova, I. V., E. L. Lozovskaia, et al. (1997). “[Antioxidant properties of a series of extracts from medicinal plants].” Biofizika 42(2): 480-3.

Davydov, M. and A D. Krikorian (2000). “Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look.” J Ethnoyharmacol 72(3): 345-93.

Hu, M., K. Konoki, et al. (1996). “Cholesterol-independent membrane disruption caused by triterpenoid saponins.” Biochim Bioyhvs Acta 1299(2): 252-8.

Iakubovskii, M. M., A A. Pentiuk, et al. (1997). “[The activity of the lipid peroxidation processes in the mucosa of the rat small intestine and its morphofunctional state under acute irradiation and the administration of combined preparations created on a base of highly dispersed silica].” Radiats Biol Radioecol 37(3): 366-71.

Lee, Y., H. Kim, et al. (1999). “Effects of water extract of 1:1 mixture of Phellodendron cortex and Aralia cortex on polyol pathway and oxidative damage in lenses of diabetic rats.” Phytother Res 13(7): 555-60.

Lee, Y. M., H. Kim, et al. (2000). “Water extract of 1:1 mixture of Phellodendron cortex and
Aralia cortex has inhibitory effects on oxidative stress in kidney of diabetic rats.”
J Ethnopharmacol 73(3): 429-36.

Martinez, B. and E. J. Staba (1984). “The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats.” Jpn J Pharmacol 35(2): 79-85.

Molokovskii, D. S., V. V. Davydov, et al. (1989). “[The action of adaptogenic plant preparations in experimental alloxan diabetes].” Probl Endokrinol (Mosk) 35(6): 82-7.

Saito, S., J. Ebashi, et al. (1993). “Comparison of cytoprotective effects of saponins isolated from leaves of Aralia elata Seem. (Araliaceae) with synthesized bisdesmosides of oleanoic acid and hederagenin on carbon tetrachloride-induced hepatic injury.” Chem Pharm Bull (Tokyo)
41(8): 1395-401.

Wang, Z., J. Hu, et al. (1997). “[Liver-protective activity of Aralia taibaiensis Z.Z. Wang et H.C. Zheng].” Zhongguo Zhong Yao Za Zhi 22(5): 307-8 inside back cover.

Yoshikawa, M., E. Harada, et al. (1993). “Elatosides A and B, potent inhibitors of ethanol absorption in rats from the bark of Aralia elata Seem: the structure-activity relationships of oleanolic acid oligoglycosides.” Chem Pharm Bull (Tokyo) 41(11): 2069-71.

Yoshikawa, M., H. Matsuda, et al. (1994). “Elatoside E, a new hypoglycemic principle from the root cortex of Aralia elata Seem.: structure-related hypoglycemic activity of oleanolic acid glycosides.” Chem Pharm Bull (Tokyo) 42(6): 1354-6.

Yoshikawa, M., T. Murakami, et al. (1996). “Bioactive saponins and glycosides. VI. Elatosides
A and B, potent inhibitors of ethanol absorption, from the bark of Aralia elata SEEM.
(Araliaceae): the structure-requirement in oleanolic acid glucuronide-saponins for the inhibitory
activity.” Chem Pharm Bull (Tokyo) 44(10): 1915-22.

Yoshikawa, M., T. Murakami, et al. (1996). “Bioactive saponins and glycosides. VII. On the hypoglycemic principles from the root cortex of Aralia elata Seem.: structure related hypoglycemic activity of oleanolic acid oligoglycoside.” Chem Pharm Bull (Tokyo) 44(10):
1923-7.

Yoshikawa, M., S. Yoshizumi, et al. (1995). “Medicinal foodstuffs. I. Hypoglycemic constituents from a garnish foodstuff”taranome,” the young shoot of Aralia elata SEEM.: elatosides G, H, I, J, and K” Chem Pharm Bull (Tokyo) 43(11): 1878-82.

al Makdessi, S., H. Sweidan, et al. (1999). “Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart.” Basic Res Cardiol 94(2):
71-7.

Al Makdessi, S., H. Sweidan, et al. (1996). “Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart.” Arzneimittelforschung 46(1): 25-7.

Bahorun, T., F. Trotin, et al. (1994). “Antioxidant activities of Crataegus monogyna extracts.” Planta Med 60(4): 323-8,

Blesken, R. (1992). “[Crataegus in cardiology].” Fortschr Med 110(15): 290-2.

Chatterjee, S. S., E. Koch, et al. (1997). “[In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms].” ArzneimitteIforschung 47(7): 821-5.

Ciplea, A.G. and K.D. Richter (1988). “The protective effect of Allium sativum and crataegus on isoprenaline-induced tissue necroses in rats.’ Arzneimittelforschung 38(11): 1583-92.

Garjani, A., H. Nazemiyeh, et al. (2000). ‘Effects of extracts from flowering tops of Crataegus meycri A. Pojark. on ischaemic arrhythrnias in anaesthetized rats.” Phytother Res 14(6): 428-31.

Guo. J. X. Zhao, et al. (1999). “[The antioxidant activity of wild jujubi, crataegus and grape in vitro].” Wei Sheng Yan Jiu 28(2): 108-10.

Holubarsch, C. J., W. S. Colucci, et al. (2000). “Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.” Eur J Heart Fail 2(4): 431-7.

Kim, S. H., K W. Kang, et al. (2000). “Procyanidins in crataegus extract evoke endotheliumdependent vasorelaxation in rat aorta.” Life Sci 67(2): 121-31.

Miller, A. L. (1998). ‘Botanical influences on cardiovascular disease.” Altern Med Rev 3(6):
422-31.

Min, B. S., H. J. Jung, et al. (1999). “Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease.” Planta Med 65(4): 374-5.

Nasa, Y., H. Hashizume, et al. (1993). ‘Protective effect of crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart.” Arzneimittelforschung 43(9):
945-9.

O’Conolly, M., W. Jansen, et al. (1986). “[Treatment of decreasing cardiac performance. Therapy using standardized crataegus extract in advanced age].” Fortschr Med 104(42): 805-8.

Periera da Silva, A., R. Rocha, et al. (2000). “Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis.” Phytother Res 14(8): 612-6.

Rajalakshmi, K., P. Gurumurthi, et al. (2000). “Effect of eugenol and tincture of crataegus (TCR) on in vitro oxidation of LDL + VLDL isolated from plasma of non-insulin dependent diabetic patients.” Indian J Exp Biol 38(5): 509-11.

Rajendran, S., P. D. Deepalakshmi, et al. (1996). “Effect of tincture of Crataegus on the LDLreceptor activity of hepatic plasma membrane of rats fed an atherogenic diet.” Atherosclerosis
123(1-2): 235-41.

Rietbrock, N., M. Hamel, et al. (2001). “[Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].” Arzneimittelforschung 51(10): 793-8.

Rothfuss, M. A., U. Pascht, et al. (2001). “Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats.” Arzneimittelforschung
51(1): 24-8.

Schmidt, U., M. Albrecht, et al (2000). “[Effects of an herbal crataegus-camphor combination on the symptoms of cardiovascular diseases].’ Arzneimittelforschung 50(7): 613-9.

Schussler, M., J. Holzl, et al. (1995). “Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 45(8): 842-5.

Schwinger, R. H., M. Pietsch, et al. (2000). “Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently.’ J Cardiovasc Pharmacol 35(5):
700-7.

Shahat, A.A., P. Cos, et al. (2002). “Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica” Planta Med 68(6): 539-41.

Shanthi, S., K. Parasakthy, et al. (1994). “Hypolipidemic activity of tincture of Crataegus in rats.” Indian J Biochem Biophys 31(2): 143-6.

Svedstrom, U., H. Vuorela, et al. (2002). “Isolation and identification of oligomeric procyanidins from Crataegus leaves and flowers.” Phytochemistry 60(8): 821-5.

Tauchert, M. (2002). “Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure.” Am Heart J 143(5): 910-5.

Tauchert, M., A. Gildor, et al. (1999). “[High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure].” Herz 24(6): 465-74; discussion 475.

Vibes, J., B. Lasserre, et al. (1994). “Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads.” Prostaglandins Leukot Essent Fatty Acids 50(4): 173-5.

Weihmayr, T. and E. Ernst (1996). “[Therapeutic effectiveness of Crataegus].” Fortschr Med 114(1-2): 27-9.

Weikl, A., K. D. Assmus, et al. (1996). “[Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)]. Fortschr Med 114(24): 291-6.

Weng, W. L., W. Q. Zhang, et al. (1984). “Therapeutic effect of Crataegus pinnatifida on 46 cases of angina pectoris--a double blind study.’ J Tradit Chin Med 4(4): 293-4.

Wittig, J., I. Leipolz, et al. (2002). “Quantification of procyanidins in oral herbal medicinal products containing extracts of Crataegus species.” Arzneimittelforschung 52(2): 89-96.

Zapfe jun, G (2001). “Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.” Phytomedicine 8(4): 262-6.

Calle, J., M. Toscano, et al. (1999). “Antinociceptive and uterine relaxant activities of Viburnum toronis alive (Caprifoliaceae). J Ethnopharmacol 66(1): 71-3.

Iwai, K.,A. Onodera, et al. (2001). “Antioxidant activity and inhibitory effect of Gamazumi (Viburnum dilatatum THUNB.) on oxidative damage induced by water immersion restraint stress in rats.” Int J Food Sci Nutr 52(5): 443-51.
Glycyrrhiza uralensis

Aliavi, A. L. and M. M. Karimov (2002). “[Use of glycyrrhiza extract in restoring local nonspecific defense of the lungs in patients with chronic obstructive bronchitis].” Vopr Kurortol Fizioter Lech Fiz Kult(2): 40-I.

Al-Qarawi, A. A., H. A. Abdel-Rahman, et al. (2002). “Liquorice (Glycyrrhiza glabra) and the adrenal-kidney-pituitary axis in rats.” Food Chem Toxicol 40(10): 1525-7.

Chang, Y. P., W. X. Bi, et al. (1989). “[Studies on the anti-virus effect of Glycyrrhiza uralensis Fish. polysaccharide].” Zhongguo Zhong Yao Za Zhi 14(4): 236-8, 255-6.

Haraguchi, H., H. Ishikawa, et al. (1998). “Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata.” Bioorg Med Chem 6(3): 339-47.

Haraguchi, H., N. Yoshida, et al. (2000). “Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra.” J Pharm Pharmacol 52(2): 219-23.

Ju, H. S., X. J. Li, et al. (1989). “[Effects of glycyrrhiza flavonoid on lipid peroxidation and active oxygen radicals].” Yao Xue Xue Bao 24(11): 807-12.

Khetagorova L. G. and A. Romanov lu (1992), “[Effects of phytoadaptogens on biorhythms of indicators of the hemostasis system in dogs],” Biull Eksp Biol Med 113(1): 87-9.

Ma, J., W. Peng, et al. (2000). “[Apoptosis of human gastric cancer cell line MGC-803 induced by glycyrrhiza uralensis extract].” Zhongguo Zhong Xi Yi Jie He Za Zhi 20(12): 928-30.

Manfredi, K. P., V. Vallurupalli, et al. (2001). “Isolation of an anti-HIV diprenylated bibenzyl from Glycyrrhiza lepidota” Phytochemistry 58(1): 153-7.

Mitscher, L. A., Y. H. Park, et al (1980). “Antimicrobial agents from higher plants. Antimicrobial isoflavanoids and related substances from Glycyrrhiza glabra L. var. typica.” J Nat
Prod 43(2): 259-69.

Raggi, M. A., F. Bugamelli, et al. (1995). “[The choleretic effects of licorice: identification and determination of the pharmacologically active components of Glycyrrhiza glabra].” Boll Chim Farm 134(11): 634-8.

Razina, T. G, E. P. Zueva, et al. (2000). “[Medicinal plant preparations used as adjuvant therapeutics in experimental oncology].” Eksp Klin Farmakol 63(5): 59-61.

Shetty, T. K., J. G. Satav, et al. (2002). “Protection of DNA and microsomal membranes in vitro by Glycyrrhiza glabra L. against gamma irradiation.” Phytother Res 16(6): 576-8.

Shim, S. B., N. J. Kim. et al. (2000). “Beta-glucuronidase inhibitory activity and hepatoprotective effect of 18 beta-glycyrrhetinic acid from the rhizomes of Glycyrrhiza uralensis.” Planta Med 66(1): 40-3.

Sitohy, M. Z., R.A. el-Massry, et al (1991). “Metabolic effects of licorice roots (Glycyrrhiza glabra) on lipid distribution pattern, liver and renal functions of albino rats. MS.” Nahrung 35(8):
799-806.

Tanaka, M., N. Mano, et al. (1987). “Inhibition of mutagenicity by glycyrrhiza extract and glycyrrhizin.” J Pharmacobiodyn 10(12): 685-8.

Wagner, H. and K. Jurcic (2002). “Immunological studies of Revitonil, a phytopharmaceutical containing Echinacea purpurea and Glycyrrhiza glabra root extract.” Phytotnedicine 9(5): 390-7.

Wang, (G. S. and Z. W. Han (1993). “[The protective action of glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice].” Yao Xue Xue Bao 28(8): 572-6.

Zani. F., M. T. Cuzzoni, et al. (1993). “Inhibition of mutagenicity in Salmonella typhimurium by
Glycyrrhiza glabra extract, glycyrrhizinic acid, 18 alpha- and 18 beta-glycyrrhetinic acids.”
Planta Med 59(6): 502-7.

Bespalov, V. G., V. A. Aleksandrov, et al. (1992). “[The inhibiting effect of phytoadaptogenic preparations from bioginseng, Eleutherococcus senticosus and Rhaponticum carthamoides on the development of nervous system tumors in rats induced by N-nitrosoethylurea.” Vopr Onkol
38(9): 1073-80.

Fu, N. W. (1988). “[Antioxidation effect of Rhaponticum uniflorum against hematoporphyrin derivative photooxidation].” Zhongguo Yi Xue Ke Xue Yuan Xue Bao 10(2): 95-9.

Gadzhieva, R. M., S. N. Portugalov, et al. (1995). “[A comparative study of the anabolic action of ecdysten, leveton and Prime Plus, preparations of plant origin].” Eksp Klin Farmakol 58(5):
46-8.

Guo, D. and Z. Lou (1992). “[Textual study of Chinese drug loulu.” Zhongguo Zhong Yao Za Zhi 17(10): 579-81 638

Kokoska, L., Z. Polesny, et al. (2002). “Screening of some Siberian medicinal plants for antimicrobial activity.’ J Ethnopharmacol 82(1): 51-3.

Lu, Y. C. (1985). ‘[Experimental study on the anti-atherosclerotic action of the Chinese medicinal Rhaponticum uniflorum].” Zhonghua Yi Xue Za Zhi 65(12): 750-3.

Lu, Y. C. (1993). “[Lipid peroxide, membrane fluidity of smooth muscle cells and atherosclerosis]” Zhonghua Bing Li Xue Za Zhi 22(1): 42-5.

Mosharrof, A. H. (1987). “Effects of extract from Rhapontcum carthamoides (Willd) Iljin (Leuzea) on learning and memory in rats.” Acta Physiol Pharmacol BuIg 13(3): 37-42.

Osipova, S. O., I. Islamova Zh, et al. (2002). “[Ecdysten in the treatment of giardiasis]. Med Parazitol (Mosk) (1): 29-33.

Petkov, V., K. Roussinov, et al. (1984). ‘Pharmacological investigations on Rhaponticum carthamoides.” Planta Med 50(3): 205-9.

Plotnikov, M. B., O. I. Aliev, et al. (2001). “[Effect of Rhaponticum carthamoides extract on hemorheological properties of blood in rats with arterial hypertension].” Eksp Klin Farmakol
64(6): 45-7.

Syrov, V. N. and A.G. Kurmukov (1976). “[Anabolic activity of phytoecdysone-ecdysterone isolated from Rhaponticum carthamoides (Willd.) Iljin].” Farmakol Toksikol 39(6): 690-3.

Syrov, V. N., A. N. Nabiev, et al (1986). “[Action of phytoecdysteroids on the bile-secretory function of the normal liver and in experimental hepatitis].” Farmakol Toksikol 49(3): 100-3.

Syrov. V. N., S. S. Nasyrova, et al. (1997). “[The results of experimental study of phytoecdysteroids as erythropoiesis stimulators in laboratory animals].” Eksp Klin Farmakol
60(3): 41-4.

Uchibayashi, M. (2001). “[Rhubarb in the East and the West].” Yakushigaku Zasshi 36(2): 171-
4.

(2002). “Rhodiola rosea. Monograph.” Altern Med Rev 7(5): 421-3.

Alekhova, T. M., A. I. Iaremenko, et al. (1996). “[The experimental evaluation of the efficacy of using a Rhodiola rosea extract for treating odontogenic inflammatory diseases].” Stomatologiia (Mosk) Spec(No): 42-3.

Azizov, A. P. and R.D. Seifulla (1998). “[The effect of elton, leveton, fitoton and adapton on the work capacity of experimental animals].” Eksp Klin Farmakol 61(3): 61-3.

Bocharova, O. A., B. P. Matveev, et al. (1995). “[The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)].” Urol Nefrol (Mosk) (2): 46-7.

Bol’shakova, I. V., E. L. Lozovskaia, et al. (1997). “[Antioxidant properties of a series of extracts from medicinal plants].” Biofizika 42(2): 480-3.

Boon-Niermeijer, E. K., A. van den Berg, et al. (2000). “Phyto-adaptogens protect against environmental stress-induced death of embryos from the freshwater snail Lymnaea stagnalis.” Phytomedicine 7(5): 389-99.

Bucci, L. R. (2000). “Selected herbals and human exercise performance.’ Am J Clin Nutr 72(2 Suppl): 624S-36S.

Chem, X., L. Di, et al. (1996). “[Hypoglycemic effect of Rhodiola sachalinensis A Bor. polysaccharides: comparison of administration in different ways].” Zhongguo Zhong Yao Za Zhi 21(11): 685-7 inside back cover.

Cheng, X. J., L. Di, et al (1993). “[Studies on the hypoglycemic effect of Rhodiola sachalinensis A. Bor polysaccharides].” Zhongguo Zhong Yao Za Zhi 18(9): 557-9, 575.

Darbinyan, V., A. Kteyan, et al. (2000). “Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.” Phytomedicine 7(5): 365-71.

Dement’eva, L. A. and K. V. Iaremenko (1987). “[Effect of a Rhodiola extract on the tumor process in an experiment].” Vopr Onkol 33(7): 57-60.

Dvornyk, A. S., T. P. Pererva, et al. (2002). “[Screening substances derived from cultures of medicinal plants for antimutagenic activity in the Escherichia coli-bacteriophage lambda system].” Tsitol Genet 36(2): 3-10.

Ha, Z., Y. Zhu, et al. (2002). “[The effect of rhodioia and acetazolamide on the sleep architecture and blood oxygen saturation in men living at high altitude].” Zhonghua Jie He He Hu Xi Za Zhi 25(9): 527-30.

Iakubovskii, M. M., A. A. Pentiuk, et al. (1997). “[The activity of the lipid peroxidation processes in the mucosa of the rat small intestine and its morphofunctional state under acute irradiation and the administration of combined preparations created on a base of highly dispersed silica].” Radiats Biol Radioecol 37(3): 366-71.

Iaremii, I. N. and N. F. Grigor’eva (2002). “[Hepatoprotective properties of liquid extract of Rhodiola rosea].” Eksp Klin Farmakol 65(6): 57-9.

Kelly, G. S. (2001). “Rhodiola rosea: a possible plant adaptogen.” Altern Med Rev 6(3): 293-
302.

Lazarova, M. B., V. D. Petkov, et al. (1986). “Effects of meclofenoxate and Extr. Rhodiolae roseae L. on electroconvulsive shock-impaired learning and memory in rats.” Methods Find Exp Clin Pharmacol 8(9): 547-52.

Lee, M. W., Y. A. Lee, et al. (2000). “Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor.” Arch Pharm Res 23(5): 455-8.

Lishmanov Iu, B., L. V. Maslova, et al. (1993). “[The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism].” Biull Eksp Biol Med 116(8): 175-6.

Lishmanov Iu, B., V. Trifonova Zh, et al. (1987). “[Plasma beta-endorphin and stress hormones in stress and adaptation].” Biull Eksp Biol Med 103(4): 422-4.

Maimeskulova, L. A. and L. N. Maslov (1998). “[The anti-arrhythmia action of an extract of
Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].” Eksp Kim Farmakol
61(2): 37-40.

Maimeskulova, L. A. and L. N. Maslov (2000). “[Anti-arrhythmic effect of phytoadaptogens].” Eksp Kiln Farmakol 63(4): 29-31.

Maimeskulova, L. A., L. N. Maslov, et al. (1997). “[The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea].” Eksp Klin Farmakol 60(1): 38-9.

Maslov, L. N., B. Lishmanov Iu, et al. (1998). “[Mechanism of the anti-arrhythmic effect of Rhodiola rosea extract].” Biull Eksp Biol Med 125(4): 424-6.

Maslova, L. V., B. Kondrat’ev, et al. (1994). “[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress].” Eksp Klin Farmakol 57(6): 61-3.

Molokovskii, D. S., V. V. Davydov, et al. (1989). “[The action of adaptogenic plant preparations in experimental alioxan diabetes].” Probl Endokrinol (Mosk) 35(6): 82-7.

Mook-Jung, I., H. Kim, et al. (2002). “Neuroprotective effects of constituents of the oriental crude drugs, Rhodiola sacra, R. sachalinensis and Tokaku-joki-to, against beta-amyloid toxicity, oxidative stress and apoptosis.” Biol Pharm Bull 25(8): 1101-4.

Nan, J. X., Y. Z. Jiang, et al. (2003). “Protective effect of Rhodiola sachalinensis extract on carbon tetrachloride-induced liver injury in rats.” J Ethnoyharmacol 84(2-3): 143-8.

Ohsugi, M., W. Fan, et al. (1999). “Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra” J Ethnopharmacol 67(1): 111-9.
9.

Pae, H. O., W. G. Seo, et al. (2001). “Rhodiola sachalinesis induces the expression of inducible nitric oxide synthase gene by murine fetal hepatocytes (BNL CL.2).” Immunopharmacol Immunotoxicol 23(1): 25-33.

Petkov, V. D., D. Yonkov, et al. (1986). “Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory.” Acta Physiol Pharmacol Bulg 12(1): 3-16.

Pogorelyi, V. E. and L. M. Makarova (2002). “[Rhodiola rosea extract for prophylaxis of ischemic cerebral circulation disorder].” Eksp Klin Farmakol 65(4): 19-22.

Provalova, N. V., E. G. Skurikhin, et al. (2002). “Mechanisms underling the effects of adaptogens on erythropoiesis during paradoxical sleep deprivation.” Bull Exp Biol Med 133(5):
428-32.

Provalova, N. V., E. G. Skurikhin, et al. (2002). ‘Effects of adaptogens on granulocytopoiesis during paradoxical sleep deprivation.” Bull Exp Biol Med 133(3): 261-4.

Razina, T. G., E. P. Zueva, et al (2000). “[Medicinal plant preparations used as adjuvant therapeutics in experimental oncology].” Eksp Klin Farmakol 63(5): 59-61.

Rege, N. N., U. M. Thatte, et al. (1999). “Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine” Phytother Res 13(4): 275-91.

Salikhova, R. A., I. V. Aleksandrova, et al. (1997). ‘[Effect of Rhodiola rosea on the yield of mutation alterations and DNA repair in bone marrow cells].” Patol Fiziol Eksp Ter (4): 22-4.

Seo, W. G., H. O. Pae, et al. (2001). “The aqueous extract of Rhodiola sachalinensis root enhances the expression of inducible nitric oxide synthase gene in RAW264.7 macrophages.”
J Ethnopharmacol 76(1): 119-23.

Spasov, A. A., V. B. Mandrikov, et al. (2000). “[The effect of the preparation rodakson on the psychophysiological and physical adaptation of students to an academic load].” Eksp Klin Farmakol 63(1): 76-8.

Spasov, A. A.. G. K Wikman, et al. (2000). “A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated 1ow-dose regimen.” Phytomedicine 7(2): 85-9.

Udintsev, S. N. and V. P. Shakhov (1989). “[Decrease in the growth rate of Ehrlich’s tumor and Pliss’ lymphosarcoma with partial hepatectomy].” Vopr Onkol 35(9): 1072-5.

Yoshikawa, M., H. Shimada, et al. (1996). “Bioactive constituents of Chinese natural medicines.
II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and
B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. (Crassulaceae).”
Chem Pharm Bull (Tokyo) 44(11): 2086-91.

Zhang, Z., J. Liu, et al. (1998). “[The effect of Rhodiola capsules on oxygen consumption of myocardium and coronary artery blood flow in dogs].” Zhongguo Zhong Yao Za Zhi 23(2): 104-6, inside back cover.

Zhang, Z. H., S. H. Feng, et a1. (1989). “[Effect of Rhodiola kirilowii (Regel.) Maxim on preventing high altitude reactions. A comparison of cardiopulmonary function in villagers at various altitudes].” Zhongguo Zhong Yao Za Zhi 14(11): 687-90, 704.
Sorbus aucuparia

Golubenko, B. G. (1967). “[Capillary resistance in patients with myocardial infarct and angina pectoris and the effect on it by anticoagulants and a preparation of Sorbus aucuparia--Vitamin CP].” Soy Med 30(4): 98-101.

Ali, N. A, J. Ludtke, et al. (1996). “Inhibition of chemiluminescence response of human mononuclear cells and suppression of mitogen-induced proliferation of spleen lymphocytes of mice by hispolon and hispidin” Pharmazie 51(9): 667-70.

Babitskaia, V. G. and V. V. Shcherba (2002). “[The nature of melanin pigments from some micro- and macromycetes].” Prikl Biokhim Mikrobiol 38(3): 286-91-

Babitskaia, V. G., V. V. Shcherba, et al. (2000). “[Melanin complex of the fungus Inonotus obliquus].” Prikl Biokhim Mikrobiol 36(4): 439-44.

Burczyk, J., A. Gawron, et al. (1996). “Antimitotic activity of aqueous extracts of Inonotus obliquus. Boll Chim Farm 135(5): 306-9.

Galasinski, W., J. Chlabicz, et al. (1996). “The substances of plant origin that inhibit protein biosynthesis.” Acta Pol Pharm 53(5): 311-8.

Golovko, V. A. (1999). “[Effects of bioglycans from birch fungus Inonotus obliquus on the electrical activity of cells from the cardiac venous sinus of the frog].” Biull Eksp Biol Med
123(9): 264-6.

Jarosz, A., M. Skorska, et al. (1990). “Effect of the extracts from fungus Inonotus obliquus on catalase level in HeLa and nocardia cells.” Acta Biochim Pol 37(1): 149-51.

Kukulianskaia, T. A., N. V. Kurchenko, et al. (2002). “[Physicochemical properties of melanins produced by Inonotus obliquus(“chagi”) in the nature and the cultivated fungus].” Prikl Biokhim Mikrobiol 38(1): 68-72.

Rasina, L. N. (2002). “[Effect of cryosubstance Chagi on deposition or isolation of 9OSr and on the effect of prolonged external exposure to gamma-radiation].” Radiats Biol Radioecol 42(4):
399-403.

Rzymowska, J. (1998). “The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities.” Boll Chim Farm 137(1): 13-5.

Saar, M. (1991). “Fungi in Khanty folk medicine.” J Ethnopharmacol 31(2): 175-9.

Wasser, S. P. and A. L. Weis (1999). “Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective.” Cut Rev Immunol 19(1): 65-96.